Bladder cancer SNP panel predicts susceptibility and survival

Human Genetics

Volumn 125, Issue 5-6, 2009, Pages 527-539

  Andrew, Angeline S ^a   Gui, Jiang ^a   Sanderson, Arthur C ^b   Mason, Rebecca A ^a   Morlock, Elaine V ^a   Schned, Alan R ^a   Kelsey, Karl T ^c   Marsit, Carmen J ^c   Moore, Jason H ^a   Karagas, Margaret R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); INTERLEUKIN 8 RECEPTOR; TELOMERASE;

ADULT; AGED; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DETOXIFICATION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; MOLECULAR EPIDEMIOLOGY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 67349189007     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-009-0645-6     Document Type: Article

References (68)

1. Ahsan H, Thomas DC (2004) Lung cancer etiology: Independent and joint effects of genetics, tobacco, and arsenic. JAMA 292:3026-3029
2. Alvarez A, Lokeshwar VB (2007) Bladder cancer biomarkers: Current developments and future implementation. Curr Opin Urol 17:341-346
3. Andrew AS, Nelson HH, Kelsey KT et al (2006) Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 27:1030-1037
4. Azzarello J, Fung KM, Lin HK (2008) Tissue distribution of human AKR1C3 and rat homolog in adult genitourinary system. J Histochem Cytochem 56(9):853-861
5. Breiman L (2001) Statistical modeling the two cultures. Stat Sci 16:199-231
6. Campbell PT, Curtin K, Ulrich C, et al. (2008) Mismatch repair polymorphisms and risk of colon cancer, tumor microsatellite instability, and interactions with lifestyle factors. Gut. doi: 10.1136/ gut.2007.144220
7. Carroll P, Raghavan D, Stein J et al. (2001) H0005 PM-the treatment of bladder cancer. Stage by Stage. AUA Annual Meeting 2001
8. Comperat E, Camparo P, Haus R et al (2007) Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: A study of 128 cases of non-invasive neoplasms. Virchows Arch 450:419-424
9. Cussenot O, Azzouzi AR, Bantsimba-Malanda G et al (2008) Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. Clin Cancer Res 14:5635-5639
10. Denzinger S, Stoehr R, Schwarz S et al (2007) Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy. Int J Oncol 31:793-802
11. Duda RO, Hart PE, Stork DG (2001) Pattern classification, 2nd edn. Wiley, New York, p 632
12. Ewart-Toland A, Dai Q, Gao YT et al (2005) Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: A meta-analysis of multiple cancer types. Carcinogenesis 26:1368-1373
13. Figueroa JD, Malats N, Garcia-Closas M et al (2008) Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis 29:1955-1962
14. Fraizer GC, Diaz MF, Lee IL et al (2004) Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int J Oncol 25:1631-1639
15. Garcia-Closas M, Malats N, Silverman D et al (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649-659
16. Garcia-Closas M, Malats N, Real FX et al (2006) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15:536-542
17. Gazzaniga P, Gradilone A, Silvestri I et al (1998) Variable levels of bcl-2, bcl-x and bax mRNA in bladder cancer progression. Oncol Rep 5:901-904
18. Gunia S, May M, Scholmann K et al (2008) Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Virchows Arch 453:165-170
19. Holden M, Deng S, Wojnowski L et al (2008) GSEA-SNP: Applying gene set enrichment analysis to SNP data from genome-wide association studies. Bioinformatics 24:2784-2785
20. Ikeda N, Toida I, Iwasaki A et al (2002) Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guerin (BCG): A role of BCG internalization into tumor cells. Int J Urol 9:29-35
21. Ito H, Kyo S, Kanaya T et al (1998) Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 4:1603-1608
22. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics. CA Cancer J Clin 57:43-66
23. Kamali-Sarvestani E, Aliparasti MR, Atefi S (2007) Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer. Neoplasma 54:484-489
24. Kantor AF, Hartge P, Hoover RN et al (1985) Familial and environmental interactions in bladder cancer risk. Int J Cancer 35:703-706
25. Karagas MR, Tosteson TD, Blum J et al (1998) Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 106(Suppl 4):1047-1050
26. Karagas MR, Park S, Nelson HH et al (2005) Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: A population-based case-control study. Int J Hyg Environ Health 208:321-327
27. Kirkali Z, Chan T, Manoharan M et al (2005) Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66:4-34
28. Kirsh EJ, Baunoch DA, Stadler WM (1998) Expression of bcl-2 and bcl-X in bladder cancer. J Urol 159:1348-1353
29. Kullback S (1959) Information theory and statistics. Wiley, New York
30. Kullback S (1987) The Kullback-Leibler distance. Am Stat 41:340-341
31. Levin AM, Zuhlke KA, Ray AM et al (2007) Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer. Prostate 67:1507-1513
32. Liu H, Jin G, Wang H et al (2008) Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: A case-control study in Chinese population. Lung Cancer 61:21-29
33. Lloyd MD, Darley DJ, Wierzbicki AS et al (2008) Alpha-methylacyl-CoA racemase-an 'obscure' metabolic enzyme takes centre stage. FEBS J 275:1089-1102
34. Macurek L, Lindqvist A, Lim D et al (2008) Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 455:119-123
35. Mantovani F, Tocco F, Girardini J et al (2007) The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol 14:912-920
36. Matarasso N, Bar-Shira A, Rozovski U et al (2007) Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate. Neoplasia 9:707-715
37. Matheson MC, Ellis JA, Raven J et al (2006) Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease. J Hum Genet 51:196-203
38. Matullo G, Guarrera S, Sacerdote C et al (2005) Polymorphisms/Haplotypes in DNA repair genes and smoking: A bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 14:2569-2578
39. Mavrommatis J, Mylona E, Gakiopoulou H et al (2005) Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancer. Anticancer Res 25:3109-3116
40. Miquel JF, Moreno M, Amigo L et al (2003) Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium. Gut 52:1017-1024
41. Mongiat-Artus P, Miquel C, Van der Aa M et al (2006) Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract. Oncogene 25:2113-2118
42. Moore JH, White BC (2007) Tuning ReliefF for Genome-Wide Genetic Analysis. Lect Notes Comput Sci 4447:166-175
43. Moore LE, Wiencke JK, Bates MN et al (2004) Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 211:199-207
44. Moore LE, Malats N, Rothman N et al (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120:2452-2458
45. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP et al (2007a) Epidemiology of urinary bladder cancer: From tumor development to patient's death. World J Urol 25:285-295
46. Murta-Nascimento C, Silverman DT, Kogevinas M et al (2007b) Risk of bladder cancer associated with family history of cancer: Do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 16:1595-1600
47. Nishihara S, Hayashida T, Mitsuya K et al (2000) Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability. Int J Oncol 17:317-322
48. Okutsu T, Kuroiwa Y, Kagitani F et al (2000) Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors. J Biochem 127:475-483
49. Ouerhani S, Oliveira E, Marrakchi R et al (2007) Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet 176:48-53
50. Palles C, Johnson N, Coupland B et al (2008) Identification of genetic variants that influence circulating IGF1 levels: A targeted search strategy. Hum Mol Genet 17:1457-1464
51. Paz MF, Avila S, Fraga MF et al (2002) Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 62:4519-4524
52. Ritchie MD, Hahn LW, Roodi N et al (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138-147
53. Ritchie MD, Hahn LW, Moore JH (2003) Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24:150-157
54. Sanyal S, De Verdier PJ, Steineck G et al (2007) Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta Oncol 46:31-41
55. Savage SA, Chanock SJ, Lissowska J et al (2007) Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer 97:832-836
56. Schned AR, Andrew AS, Marsit CJ et al (2007) Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology Versus WHO Classification Systems. J Urol 178:1196-1200
57. Schultz IJ, Kiemeney LA, Roelofs R et al (2007) The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma. Anticancer Res 27:1025-1030
58. Takahashi K, Uchida C, Shin RW et al (2008) Prolyl isomerase, Pin1: New findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. Cell Mol Life Sci 65:359-375
59. Thykjaer T, Christensen M, Clark AB et al (2001) Functional analysis of the mismatch repair system in bladder cancer. Br J Cancer 85:568-575
60. van Dijk B, van Houwelingen KP, Witjes JA et al (2001) Alcohol dehydrogenase type 3 (ADH3) and the risk of bladder cancer. Eur Urol 40:509-514
61. Vineis P, Veglia F, Garte S et al (2007) Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann Oncol 18:1230-1242
62. Wang L, Ke Q, Chen W et al (2007) Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin Cancer Res 13:2526-2532
63. Wong HL, Koh WP, Probst-Hensch NM et al (2008) Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: A functional genomics approach. Gut 57:1090-1096
64. Wu X, Gu J, Grossman HB et al (2006) Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78:464-479
65. Xing J, Zhu Y, Zhao H et al (2007) Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev 16:606-609
66. Yamamoto Y, Matsuyama H, Kawauchi S et al (2006) Overexpression of Polo-Like Kinase 1 (PLK1) and chromosomal instability in bladder cancer. Oncology 70:231-237
67. Yuan SY, Hsu SL, Tsai KJ et al (2002) Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells. Urol Res 30:282-288
68. Zenser TV, Lakshmi VM, Hsu FF et al (2002) Metabolism of N-acetylbenzidine and initiation of bladder cancer. Mutat Res 506-507:29-40